About one in ten people say they avoid gluten or wheat because it makes them sick — but that number lumps together several very different conditions. A new letter published in Gut from Italian pediatric researchers argues that figure obscures more than it reveals. The authors call for sorting these self-reporters into meaningful subgroups, a process that could change how patients get diagnosed, how clinicians prioritize care, and — for celiac families — how seriously the gluten-free label gets taken.
What This Means for You
For celiac families, this debate has practical consequences. Celiac disease affects roughly 1% of the population. Non-celiac gluten and wheat sensitivity, by contrast, is claimed by far more people — estimates run from 6% to 13% depending on the country and survey method. That mismatch shapes nearly everything: how restaurant staff respond to gluten-free requests, how schools handle food concerns, how quickly doctors order celiac testing.
When a waiter hears “gluten-free,” their mental image may well be a lifestyle preference, not a medical necessity. That perception is partly a product of the self-reported sensitivity label being applied across an enormous and varied group. Some of those people almost certainly have undiagnosed celiac disease. Others may react to carbohydrates in wheat rather than to gluten itself. Still others may have symptoms driven by the gut-brain axis. Treating all of them as interchangeable has real costs.
The University of Bari team’s core argument is that stratifying self-reporters — sorting them into specific, well-defined categories — gives clinicians a clearer map to work from. Getting those categories right is not a bureaucratic exercise. It’s the difference between a correct diagnosis and years of unnecessary restriction, or worse, a missed celiac diagnosis in a child who needed one.
For the celiac community, better stratification also matters culturally. The broader and looser the gluten-sensitivity label becomes, the harder celiac families must work to communicate that a diagnosis carries medical weight. That challenge plays out at birthday parties, in school cafeterias, and at every restaurant table where someone is weighing whether to take the request seriously.
Key Takeaways
- Roughly 1 in 10 people self-report gluten or wheat sensitivity — but confirmed cases are far rarer when patients undergo formal testing.
- The non-celiac gluten sensitivity label currently covers multiple distinct conditions, some of which may not involve gluten at all.
- Sorting self-reporters into specific subgroups could identify people with undiagnosed celiac disease before they lose the opportunity for accurate testing.
- Better categorization may strengthen the credibility of gluten-free medical needs in food service and school settings.
- The research comes from a pediatric team, making it directly relevant to families raising children with celiac disease.
The Science
Want to understand how this actually works? The technical details below define every term along the way. No medical degree required.
What Is Non-Celiac Gluten/Wheat Sensitivity?
Non-celiac gluten sensitivity (NCGS) is a condition in which people experience symptoms — digestive, neurological, or skin-related — after eating gluten, but without the autoimmune intestinal damage that defines celiac disease and without a wheat allergy. The closely related term non-celiac wheat sensitivity (NCWS) acknowledges that components of wheat other than gluten might be driving symptoms in some patients.
The diagnostic challenge is significant: no validated biomarker confirms NCGS. The gold standard is a double-blind, placebo-controlled gluten challenge — a formal protocol where patients consume either gluten or a look-alike placebo without knowing which, and researchers track whether symptoms reliably follow actual gluten exposure. When self-reported cases are put through this protocol, most do not demonstrate reproducible sensitivity to gluten. The gap between perceived and confirmed sensitivity is wide.
The “One in Ten” Problem
The 1-in-10 figure in the paper’s title comes from population surveys that ask people whether they experience symptoms they attribute to gluten or wheat. These surveys capture self-perception, not biological confirmation. Challenge-based studies place confirmed NCGS rates considerably lower.
That discrepancy is the problem the Bari researchers are pointing at. A figure derived from self-report does not tell clinicians how many patients need which intervention — it just tells them how many people believe they have a problem with gluten. Those are different questions.
Why Stratification Matters
Stratifying a patient group means dividing it into subgroups by cause, presentation, or treatment response. In the NCGS context, several distinct subgroups have been proposed in the research literature:
- Undiagnosed celiac disease: Some self-reporters have never been tested for celiac. Given that celiac remains significantly underdiagnosed globally, this group almost certainly exists within the self-reporter pool — and these patients need strict lifelong gluten elimination, not just a loosely gluten-reduced diet.
- Wheat allergy: A distinct immune response to wheat proteins — separate from celiac’s autoimmune mechanism — that can cause symptoms from digestive upset to anaphylaxis.
- FODMAP sensitivity: FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) are short-chain carbohydrates found in wheat and many other foods. Some people react to these carbohydrates rather than to gluten itself. A low-FODMAP diet may be the appropriate path for this group — not a strict gluten-free protocol.
- True NCGS: People who, through formal challenge, consistently react to gluten and not to placebo. This group exists, but it is smaller than population surveys suggest.
- Nocebo responders: People whose symptoms are driven by the expectation of harm rather than a direct biological response to gluten. This is a documented physiological phenomenon, not a dismissal. It points toward a therapeutic approach that has nothing to do with diet modification.
Each of these groups needs a different response. Giving a FODMAP-sensitive patient the same strict avoidance protocol as a celiac patient may cause unnecessary restriction. Leaving an undiagnosed celiac patient in the “probably NCGS” category delays treatment and risks long-term complications.
Why Pediatric Framing Matters Here
The Bari research team works in a pediatric hospital setting — and that context is worth noting for celiac families. Children who report gut symptoms after eating wheat may never receive a formal workup if clinicians and parents assume the culprit is a vague sensitivity rather than celiac disease. Because accurate celiac antibody testing requires active gluten consumption, children who adopt a gluten-free diet based on self-reported sensitivity may quietly close the window for a correct diagnosis.
There is also a social dimension. My son has celiac disease, and the families I encounter in this community know how hard it is to communicate the seriousness of that diagnosis in a world where many people also describe themselves as gluten-sensitive. Stratification research matters not just clinically but practically — the more precisely clinicians and researchers can define these categories, the easier it becomes to explain why celiac is different.
Our earlier coverage of celiac disease prevalence in patients diagnosed with IBS documented a related diagnostic gap: patients whose celiac disease was misread as irritable bowel syndrome for years. The NCGS overlap is another version of that problem — different label, same delay. And as we reported in our piece on ARFID in celiac and NCGS patients, poorly defined food sensitivity diagnoses can feed restrictive eating patterns that go well beyond what the medical picture requires. Clearer stratification is one step toward preventing that.
The Bari team’s letter is a call to the field to move past a convenient but imprecise statistic. For celiac patients, caregivers, and clinicians, that kind of precision is not an academic luxury. It is the foundation of a correct diagnosis.
Related Coverage
- Avoidant/Restrictive Food Intake Disorder Is Common in Adult and Pediatric Patients with Celiac Disease and Non-Celiac Gluten Sensitivity
- Prevalence and predictors of coeliac disease in patients with irritable bowel syndrome: A prospective study from Rajasthan, India
References
Cristofori F, Brindicci VF, Castellaneta SP, Dargenio VN, Francavilla R. Beyond ‘one in ten’: stratifying self-reported non-coeliac gluten/wheat sensitivity. Gut. 2026 Aug 7. doi: 10.1136/gutjnl-2026-339370. PubMed